JP2023520929A5 - - Google Patents
Info
- Publication number
- JP2023520929A5 JP2023520929A5 JP2022561484A JP2022561484A JP2023520929A5 JP 2023520929 A5 JP2023520929 A5 JP 2023520929A5 JP 2022561484 A JP2022561484 A JP 2022561484A JP 2022561484 A JP2022561484 A JP 2022561484A JP 2023520929 A5 JP2023520929 A5 JP 2023520929A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063008624P | 2020-04-10 | 2020-04-10 | |
| US63/008,624 | 2020-04-10 | ||
| US202063023021P | 2020-05-11 | 2020-05-11 | |
| US63/023,021 | 2020-05-11 | ||
| US16/875,487 | 2020-05-15 | ||
| US16/875,487 US11116737B1 (en) | 2020-04-10 | 2020-05-15 | Methods of using probenecid for treatment of coronavirus infections |
| EP20202059.0 | 2020-10-15 | ||
| EP20202059.0A EP3892269B1 (en) | 2020-04-10 | 2020-10-15 | Probenecid for treating coronavirus infections |
| US202163151551P | 2021-02-19 | 2021-02-19 | |
| US63/151,551 | 2021-02-19 | ||
| PCT/US2021/026588 WO2021207606A1 (en) | 2020-04-10 | 2021-04-09 | Methods for treatment of coronavirus infections |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2023520929A JP2023520929A (ja) | 2023-05-22 |
| JP2023520929A5 true JP2023520929A5 (https=) | 2024-04-16 |
| JPWO2021207606A5 JPWO2021207606A5 (https=) | 2024-04-16 |
| JP7840570B2 JP7840570B2 (ja) | 2026-04-06 |
Family
ID=78023981
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561484A Active JP7840570B2 (ja) | 2020-04-10 | 2021-04-09 | コロナウイルス感染症の処置のための方法 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP4132503B1 (https=) |
| JP (1) | JP7840570B2 (https=) |
| CN (1) | CN116075298B (https=) |
| AU (1) | AU2021254262A1 (https=) |
| WO (1) | WO2021207606A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4157288A2 (en) * | 2020-06-02 | 2023-04-05 | Institut Gustave-Roussy | Modulators of purinergic receptors and related immune checkpoint for treating acute respiratory distress syndrom |
| JP2024529291A (ja) * | 2021-07-06 | 2024-08-06 | ユニバーシティ・オブ・ジョージア・リサーチ・ファウンデイション・インコーポレイテッド | ウイルス感染症の処置および予防のための組成物および方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005005596A2 (en) * | 2003-06-18 | 2005-01-20 | Chinese National Human Genome Center At Shanghai | Characterization of the earliest stages of the severe acute respiratory syndrome (sars) virus and uses thereof |
| MX341050B (es) * | 2010-04-07 | 2016-08-05 | Celgene Corp * | Metodos para tratar infeccion viral respiratoria. |
| US20130280806A1 (en) * | 2010-05-17 | 2013-10-24 | Donald Rubin | Mammalian genes involved in infection |
| US11554112B2 (en) * | 2018-06-07 | 2023-01-17 | Herum Therapeutics International Limited | Combinations of β-lactam compounds and probenecid and uses thereof |
| CN111601618A (zh) * | 2018-09-14 | 2020-08-28 | 江阴贝瑞森制药有限公司 | 孟鲁司特与肽的新缀合物 |
| EA202193251A1 (ru) * | 2019-06-05 | 2022-03-10 | Эмори Юниверсити | Пептидомиметики для лечения коронавирусной и пикорнавирусной инфекций |
-
2021
- 2021-04-09 WO PCT/US2021/026588 patent/WO2021207606A1/en not_active Ceased
- 2021-04-09 EP EP21785329.0A patent/EP4132503B1/en active Active
- 2021-04-09 JP JP2022561484A patent/JP7840570B2/ja active Active
- 2021-04-09 CN CN202180037562.1A patent/CN116075298B/zh active Active
- 2021-04-09 AU AU2021254262A patent/AU2021254262A1/en active Pending